Rock Springs Capital Management LP Q4 2023 Filing
Filed February 14, 2024
Portfolio Value
$4.1B
Holdings
104
Report Date
Q4 2023
Filing Type
13F-HR
All Holdings (104 positions)
| # | Stock | Shares | Value | % Portfolio | Type |
|---|---|---|---|---|---|
| 101 | XLOXILIO THERAPEUTICS INC | 1,440,759 | $792.4B | 19507.24% | |
| 102 | NVRO 2.75 04/01/25NEVRO CORP | 500,000 | $481.8B | 11860.56% | |
| 103 | TLPHACELRX PHARMACEUTICALS INC | 316,460 | $232.6B | 5725.96% | |
| 104 | NUVB/WSNUVATION BIO INC | 134,028 | $8.0B | 197.97% |
PreviousPage 2 of 2